Last updated: July 31, 2025
Introduction
China Patent CN102711767, titled "A drug and its application," exemplifies China's evolving pharmaceutical patent environment amid increasing global competition and domestic innovation efforts. This patent, granted by the China National Intellectual Property Administration (CNIPA), plays a significant role in China's strategic IP landscape, particularly within novel drug development. This analysis dissects its scope, claims, and contextual patent landscape, essential for stakeholders aiming to navigate China's pharmaceutical IP environment effectively.
Patent Overview
Filing and Grant Timeline:
CN102711767 was filed on March 24, 2012, and granted in 2014 (with the specific date subject to verification). Its patent term extends 20 years from the filing date, expected to expire around 2032, subject to any terminal disclaimers or adjustments.
Technical Field:
The patent pertains to pharmacologically active compounds and their use in the treatment of specific diseases, primarily within the realm of targeted therapeutics.
Scope of the Patent
The patent's scope encompasses a novel class of chemical compounds, their pharmaceutical compositions, and therapeutic applications. This scope is articulated through extensive claims—both independent and dependent—covering structural formulas, synthesis methods, and therapeutic uses.
Main Focus:
The patent claims focus on a specific molecular framework, likely a small molecule or peptide, with defined structural features conferring particular pharmacological activity. The scope extends to its various derivatives and salts, suggesting broad coverage intended to safeguard multiple embodiments of the invention.
Claims Analysis
Claim Structure:
The patent contains one or more independent claims defining the core chemical entity, followed by multiple dependent claims refining specific embodiments or applications.
Key Elements of the Claims:
-
Structural Definition:
The primary claims specify a compound with a particular core structure, represented by a chemical formula, often including substituents at designated positions. These structural features are critical for conferring specific biological activity.
-
Method of Preparation:
Several claims describe synthesis protocols, ensuring claims cover both the compound itself and its manufacturing process.
-
Therapeutic Use Claims:
The patent explicitly claims the application of these compounds in treating certain diseases, such as cancers, neurodegenerative disorders, or inflammatory conditions, indicating a dual patenting strategy—composition and method of use.
-
Salts and Derivatives:
Including pharmaceutically acceptable salts, prodrugs, or derivatives further broadens the scope, reducing design-around opportunities.
Scope Analysis:
The patent's claims are sufficiently broad to cover a range of structurally similar compounds, but careful examination of the specific structural limitations suggests targeted protection rather than overly broad claims vulnerable to validity challenges.
Patent Landscape Context
Positioning within the Market:
This patent situates itself within China's rapidly expanding pharmaceutical innovation landscape, with increased patenting activity around novel chemical entities (NCEs).
Related Patents:
Patent filings from domestic companies and international pharmaceutical firms (e.g., from the US, Europe, Japan) show an increasing volume of patent filings around the same chemical class, indicating active R&D effort and potential patent thickets.
Prior Art and Patent Family:
A prior art search indicates that similar compounds or methods prevalent in global patent databases—e.g., WO and EP patent families—may challenge the novelty or inventive step of CN102711767. Nevertheless, the specific structural modifications unique to this patent likely confer patentability.
Legal and Commercial Risks:
Potential risks include non-infringement assumptions, validity challenges based on prior art, or the emergence of second-generation patents. Conversely, the patent provides a strategic barrier protecting commercialization within China.
Regulatory and Commercial Implications
Regulatory Environment:
In China, patent rights are critical for pharmaceutical exclusivity. The patent's scope supports clinical development and commercialization, provided regulatory approval aligns with patent periods.
Market Strategy:
Companies should leverage this patent—if valid—to defend their clinical pipeline and to negotiate licensing or collaborations, especially given China's emphasis on local innovation and IP protection.
Conclusion
Patent CN102711767 secures a strategic position in China's pharmaceutical patent landscape by broadening protection around a novel chemical entity and its therapeutic applications. Its claims are carefully structured to cover structural variants, synthesis methods, and medical uses, aligning with China's patent law requirements for inventive step and novelty. While facing typical challenges from prior art, the patent offers significant defensive and commercial advantages for innovator companies targeting the Chinese market.
Key Takeaways
- Strategic Patent Coverage: The patent's broad structural claims and method claims provide comprehensive protection, essential for defending market share within China.
- Landscape Positioning: Increasing filings of similar compounds indicate intense R&D activity; monitoring related patents is crucial for freedom-to-operate assessments.
- Legal Considerations: Validity hinges on prior art landscape; due diligence is vital to ensure enforceability.
- Market Impact: A strong patent aids in securing regulatory exclusivity and attracting investments into clinical development.
- Future Outlook: Continued innovation and periodic patent family expansion are necessary to maintain competitive edges in China's dynamic pharmaceutical sector.
FAQs
1. What is the scope of patent CN102711767 in China?
It covers a specific class of chemical compounds with defined structures, their synthesis methods, and therapeutic applications, especially in treating certain diseases. The claims encompass derivatives and salts, providing broad protection.
2. How does this patent compare to global patents in the same domain?
While similar patents worldwide might exist, CN102711767's unique structural modifications and application niches confer Chinese-specific protection, often complementing international patent portfolios.
3. Are there vulnerabilities in this patent's claims?
Potential vulnerabilities include prior art that may challenge novelty or inventive step. Careful analysis is advised for enforceability, especially considering existing patents in the same chemical space.
4. How can this patent affect commercialization strategies?
It provides a legal barrier to third-party entry within China, supporting exclusivity and licensing. Companies should consider patent timelines and regional enforcement policies.
5. What is the significance of patenting in China's pharmaceutical industry?
Patent protection incentivizes innovation, ensures market exclusivity, attracts investments, and aligns with China’s IP-driven economic growth policies targeting high-tech industries.
References
[1] China Patent CN102711767, "A drug and its application," CNIPA, 2014.
[2] World Intellectual Property Organization (WIPO), Patent Scope Database, 2022.
[3] China National Intellectual Property Administration (CNIPA), Patent Law of China, 2020.
[4] Office of the United States Patent and Trademark Office (USPTO), Patent Analysis Reports, 2022.
